Response to Comment on “Cathepsin-L Influences the Expression of Extracellular Matrix in Lymphoid Organs and Plays a Role in the Regulation of Thymic Output and of Peripheral T Cell Number”
暂无分享,去创建一个
G. Lombardi | Juliana Mundiñano | Gabriela Lombardi | Dalia Burzyn | Juliana Mundiñano | Paula Berguer | Hector Costa | Alejandra Goldman | Isabel Piazzon | Irene Nepomnaschy | Dalia Burzyn | A. Goldman | I. Nepomnaschy | P. Berguer | I. Piazzón | H. Costa
[1] R. N. Brogden,et al. Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders. , 1993, Drugs.
[2] S. Rosenberg,et al. Analysis of the Cellular Mechanism of Antitumor Responses and Autoimmunity in Patients Treated with CTLA-4 Blockade , 2005, The Journal of Immunology.
[3] P. Bekinschtein,et al. Cathepsin-L Influences the Expression of Extracellular Matrix in Lymphoid Organs and Plays a Role in the Regulation of Thymic Output and of Peripheral T Cell Number1 , 2005, The Journal of Immunology.
[4] J. Aarseth,et al. IL‐6: an early marker for outcome in acute ischemic stroke , 2005, Acta neurologica Scandinavica.
[5] M. Eisenhut. Comment on “Pretreatment Intracerebral and Peripheral Blood Immune Responses in Vietnamese Adults with Tuberculous Meningitis: Diagnostic Value and Relationship to Disease Severity and Outcome” , 2006, The Journal of Immunology.
[6] A. Rudensky,et al. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. , 1998, Science.
[7] R. Maciewicz,et al. Cathepsin L‐deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy , 2004, International journal of experimental pathology.
[8] K. Matsushima,et al. Absence of IL-1 Receptor Antagonist Impaired Wound Healing along with Aberrant NF-κB Activation and a Reciprocal Suppression of TGF-β Signal Pathway1 , 2006, The Journal of Immunology.
[9] N. Kohno,et al. Interleukin 6 activity in pleural effusion. Its diagnostic value and thrombopoietic activity. , 1992, Chest.
[10] J. Parrillo,et al. Adenosine deaminase inhibition attenuates microvascular dysfunction and improves survival in sepsis. , 2002, American journal of respiratory and critical care medicine.
[11] M. Willingham,et al. Involvement of carboxy-terminal amino acids in secretion of human lysosomal protease cathepsin L. , 1998, Biochemistry.
[12] J. Farrar,et al. Pretreatment Intracerebral and Peripheral Blood Immune Responses in Vietnamese Adults with Tuberculous Meningitis: Diagnostic Value and Relationship to Disease Severity and Outcome , 2006, The Journal of Immunology.
[13] M. Gottesman,et al. Activity and deletion analysis of recombinant human cathepsin L expressed in Escherichia coli. , 1989, The Journal of biological chemistry.
[14] S. Ho,et al. Cerebral Infarcts Complicating Tuberculous Meningitis , 2005, Cerebrovascular Diseases.
[15] T. Gallart,et al. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Guénet,et al. The Radiation-Induced nackt (nkt) Allele Is a Loss-of-Function Mutation of the Mouse Cathepsin L Gene , 2006, Journal of Immunology.
[17] M. Eisenhut,et al. Cerebrospinal Fluid Adenosine Deaminase Levels and Adverse Neurological Outcome in Pediatric Tuberculous Meningitis , 2005, Infection.